Canadian Agency for Drugs and Technologies in Health. (2017). Patient group input submissions AbobotulinumtoxinA (Dysport therapeutic) (Ipsen Biopharmaceuticals Canada, Inc.). Canadian Agency for Drugs and Technologies in Health.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Patient Group Input Submissions AbobotulinumtoxinA (Dysport Therapeutic) (Ipsen Biopharmaceuticals Canada, Inc.). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Patient Group Input Submissions AbobotulinumtoxinA (Dysport Therapeutic) (Ipsen Biopharmaceuticals Canada, Inc.). Canadian Agency for Drugs and Technologies in Health, 2017.
Warning: These citations may not always be 100% accurate.